{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:44:54Z","timestamp":1794663894291,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-018-1159-7","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T11:02:13Z","timestamp":1537959733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hye","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonhye","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danbee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong Rae","family":"Joi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Young","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pastor-Barriuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Yun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"1159_CR1","unstructured":"GOLD. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. (2018 Report) Available from \n                    www.goldcopd.org\n                    \n                  . Assessed 1 June 2018."},{"key":"1159_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1183\/09031936.06.00025805","volume":"27","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27:397\u2013412.","journal-title":"Eur Respir J"},{"key":"1159_CR3","unstructured":"World Health Organization. Projecitons of mortaity and causes of death, 2015 and 2030. Available at: \n                    http:\/\/www.who.int\/healthinfo\/global_burden_disease\/projections\/en\/\n                    \n                  . Assessed 1 June 2018."},{"key":"1159_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","volume":"187","author":"LE Vanfleteren","year":"2013","unstructured":"Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728\u201335.","journal-title":"Am J Respir Crit Care Med"},{"key":"1159_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12931-017-0512-2","volume":"18","author":"JA Westerik","year":"2017","unstructured":"Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017;18:31.","journal-title":"Respir Res"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"e0132670","DOI":"10.1371\/journal.pone.0132670","volume":"10","author":"MB Huber","year":"2015","unstructured":"Huber MB, Wacker ME, Vogelmeier CF, Leidl R. Comorbid influences on generic health-related quality of life in COPD: a systematic review. PLoS One. 2015;10:e0132670.","journal-title":"PLoS One"},{"key":"1159_CR7","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.5888\/pcd14.160333","volume":"14","author":"G Westney","year":"2017","unstructured":"Westney G, Foreman MG, Xu J, Henriques King M, Flenaugh E, Rust G. Impact of comorbidities among Medicaid enrollees with chronic obstructive pulmonary disease, United States, 2009. Prev Chronic Dis. 2017;14:E31.","journal-title":"Prev Chronic Dis"},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1183\/09031936.00133805","volume":"28","author":"DD Sin","year":"2006","unstructured":"Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28:1245\u201357.","journal-title":"Eur Respir J"},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa033250","volume":"354","author":"CA Haiman","year":"2006","unstructured":"Haiman CA, Stram DO, Wilkens LR, Pike MC, Kolonel LN, Henderson BE, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med. 2006;354:333\u201342.","journal-title":"N Engl J Med"},{"key":"1159_CR10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","volume":"168","author":"H Bahrami","year":"2008","unstructured":"Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:2138\u201345.","journal-title":"Arch Intern Med"},{"key":"1159_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1212\/WNL.0000000000000237","volume":"82","author":"J Gutierrez","year":"2014","unstructured":"Gutierrez J, Williams OA. A decade of racial and ethnic stroke disparities in the United States. Neurology. 2014;82:1080\u20132.","journal-title":"Neurology"},{"key":"1159_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1411532","volume":"373","author":"P Lange","year":"2015","unstructured":"Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373:111\u201322.","journal-title":"N Engl J Med"},{"key":"1159_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"1159_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"1159_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4046\/trd.2005.58.3.230","volume":"58","author":"JK Choi","year":"2005","unstructured":"Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis. 2005;58:230\u201342.","journal-title":"Tuberc Respir Dis"},{"key":"1159_CR16","volume-title":"Physical Status: The use and interpretation of anthropometry: report of a World Health Organization (WHO) expert committee","author":"WHO","year":"1995","unstructured":"WHO. Physical Status: The use and interpretation of anthropometry: report of a World Health Organization (WHO) expert committee. Geneva: World Health Organization; 1995."},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1001\/jama.2016.15450","volume":"316","author":"K Bibbins-Domingo","year":"2016","unstructured":"Force USPST, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, et al. Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement. JAMA. 2016;316:1997\u20132007.","journal-title":"JAMA"},{"key":"1159_CR18","volume-title":"Haemoglobin concentrations for the diagnosis of Anaemia and assessment of severity. Vitamin and mineral nutrition information system","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Haemoglobin concentrations for the diagnosis of Anaemia and assessment of severity. Vitamin and mineral nutrition information system. Geneva: World Health Organization; 2011. Available from: \n                    http:\/\/www.who.int\/vmnis\/indicators\/haemoglobin.pdf\n                    \n                  . Accessed 1 July 2018"},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1513\/pats.200404-032MS","volume":"2","author":"DD Sin","year":"2005","unstructured":"Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2:8\u201311.","journal-title":"Proc Am Thorac Soc"},{"key":"1159_CR20","first-page":"105","volume":"1","author":"N Putcha","year":"2014","unstructured":"Putcha N, Han MK, Martinez CH, Foreman MG, Anzueto AR, Casaburi R, et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chronic Obstr Pulm Dis. 2014;1:105\u201314.","journal-title":"Chronic Obstr Pulm Dis"},{"key":"1159_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1378\/chest.128.3.1201","volume":"128","author":"A Chambellan","year":"2005","unstructured":"Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005;128:1201\u20138.","journal-title":"Chest"},{"key":"1159_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/15412555.2011.647131","volume":"9","author":"C Martinez-Rivera","year":"2012","unstructured":"Martinez-Rivera C, Portillo K, Munoz-Ferrer A, Martinez-Ortiz ML, Molins E, Serra P, et al. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD. 2012;9:243\u201350.","journal-title":"COPD."},{"key":"1159_CR23","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.21037\/jtd.2017.10.140","volume":"9","author":"YM Oh","year":"2017","unstructured":"Oh YM, Park JH, Kim EK, Hwang SC, Kim HJ, Kang DR, et al. Anemia as a clinical marker of stable chronic obstructive pulmonary disease in the Korean obstructive lung disease cohort. J Thorac Dis. 2017;9:5008\u201316.","journal-title":"J Thorac Dis"},{"key":"1159_CR24","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.2147\/COPD.S159249","volume":"13","author":"SC Park","year":"2018","unstructured":"Park SC, Kim YS, Kang YA, Park EC, Shin CS, Kim DW, et al. Hemoglobin and mortality in patients with COPD: a nationwide population-based cohort study. Int J Chron Obstruct Pulmon Dis. 2018;13:1599\u2013605.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1097\/00003246-199811000-00022","volume":"26","author":"B Schonhofer","year":"1998","unstructured":"Schonhofer B, Wenzel M, Geibel M, Kohler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary disease. Crit Care Med. 1998;26:1824\u20138.","journal-title":"Crit Care Med"},{"key":"1159_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2466-14-24","volume":"14","author":"DS Silverberg","year":"2014","unstructured":"Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G. Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med. 2014;14:24.","journal-title":"BMC Pulm Med"},{"key":"1159_CR27","unstructured":"Centers for Disease Control and Prevention. CDC Health Disparities and Inequalities Report \u2014 United States, 2013. \n                    https:\/\/www.cdc.gov\/mmwr\/pdf\/other\/su6203.pdf\n                    \n                  . Accessed 1 June 2018."},{"key":"1159_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S2213-2600(12)70060-7","volume":"1","author":"M Decramer","year":"2013","unstructured":"Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med. 2013;1:73\u201383.","journal-title":"Lancet Respir Med"},{"key":"1159_CR29","first-page":"95","volume":"10","author":"G Hillas","year":"2015","unstructured":"Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95\u2013109.","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIR.0000000000000071","volume":"130","author":"CJ Rodriguez","year":"2014","unstructured":"Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, et al. Status of cardiovascular disease and stroke in Hispanics\/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593\u2013625.","journal-title":"Circulation"},{"key":"1159_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1513\/AnnalsATS.201312-438FR","volume":"11","author":"DE O\u2019Donnell","year":"2014","unstructured":"O\u2019Donnell DE, Ciavaglia CE, Neder JA. When obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequences. Ann Am Thorac Soc. 2014;11:635\u201344.","journal-title":"Ann Am Thorac Soc"},{"key":"1159_CR32","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/15412555.2015.1087991","volume":"13","author":"P Katz","year":"2016","unstructured":"Katz P, Iribarren C, Sanchez G, Blanc PD. Obesity and functioning among individuals with chronic obstructive pulmonary disease (COPD). COPD. 2016;13:352\u20139.","journal-title":"COPD"},{"key":"1159_CR33","first-page":"31","volume":"8","author":"YM Oh","year":"2013","unstructured":"Oh YM, Bhome AB, Boonsawat W, Gunasekera KD, Madegedara D, Idolor L, et al. Characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven Asian cities. Int J Chron Obstruct Pulmon Dis. 2013;8:31\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1159-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-018-1159-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1159-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:15:36Z","timestamp":1570130136000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-018-1159-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1186\/s12916-018-1159-7","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,4]]},"assertion":[{"value":"13 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As we used publicly available data, our institutions waived the need for ethical approval. The original U.S. NHANES and KNHANES surveys we used were approved by the relevant institutional review boards and all participants provided written, informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HYP has received lecture fees from AstraZeneca, Novartis, and Boehringer-Ingelheim. HL, SHS, SG, DZ, DK, YRJ, GYS, RP, EG, and JC have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"178"}}